Benjamin Hickey
Präsident bei RAYZEBIO, INC.
Vermögen: 35 789 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Benjamin Hickey
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
| Subsidiary | Biotechnology | 33 | |
| Public Company | Biotechnology | 19 | |
| Subsidiary | Biotechnology | 15 | |
| Public Company | Biotechnology | 15 | |
Bristol-Myers Squibb Holdings 2002 Ltd.
 Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings 2002 Ltd. is a holding British company that operates subsidiaries distributing and selling pharmaceutical products. The company is based in Uxbridge, UK.
2
| Subsidiary | Medical Distributors | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benjamin Hickey
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member President | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Secretary Director/Board Member Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| CELGENE | Biotechnology | President Director/Board Member Chief Tech/Sci/R&D Officer | |
| Georgetown University | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| METACRINE, INC. | Biotechnology | Director/Board Member Founder Chief Executive Officer | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Investor Relations Contact Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Chairman General Counsel | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member General Counsel | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chief Executive Officer Chairman | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stephen M. Ross School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 3 |
| Niederlande | 2 |
Sektoral
| Health Technology | 37 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 419 |
| Corporate Officer/Principal | 224 |
| Independent Dir/Board Member | 173 |
| Chief Executive Officer | 84 |
| Undergraduate Degree | 81 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carol Gallagher | 39 |
| Richard Heyman | 33 |
| Michael Grey | 32 |
| Julie Cherrington | 32 |
| Maha Katabi | 28 |
| Faheem Hasnain | 27 |
| Bruce Carter | 25 |
| James Cornelius | 23 |
| Dave Grayzel | 23 |
| Charles Sigal | 20 |
| David Meek | 19 |
| Aaron Kantoff | 19 |
| Aaron Davis | 19 |
| Denice Torres | 19 |
| Matt Roden | 18 |
- Börse
- Insiders
- Benjamin Hickey
- Unternehmensverbindungen
